Scarica l'app Stockscreener
158.52
0.37%
0.59
Pre-mercato:
161.60
3.08
+1.94%
Irhythm Technologies Inc Borsa (IRTC) Ultime notizie
iRhythm Technologies (IRTC) Surpasses Q2 Revenue Forecasts, Raises Outlook - MSN
AVALON Study Builds on CAMELOT Study Reinforcing iRhythm’s LTCM Clinical Performance - Diagnostic and Interventional Cardiology
iRhythm Technologies falls after Spruce Point issues short-selling report - TradingView
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies - Benzinga
Spruce Point issues strong sell report on iRhythm Technologies - MarketScreener
Spruce Point says it’s short iRhythm, sees 40%-70% potential LT downside - TipRanks
Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on iRhythm Technologies (NASDAQ: IRTC) - Business Wire
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority - The Manila Times
428,707-Patient Study: iRhythm's Heart Monitor Doubles Diagnosis Rate, Cuts Healthcare Costs by $816/Patient - Stock Titan
iRhythm Technologies Inc. Crosses 200 Day MA — Signal or Noise2025 Technical Patterns & Fast Entry and Exit Trade Plans - sundaytimes.kr
Introducing the CSO finalists in our C-Suite Leaders Awards - The Business Journals
Published on: 2025-08-14 23:53:49 - classian.co.kr
ECG Patch and Holter Monitor Market Set to Witness Significant - openPR.com
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know - Yahoo Finance
Local health-tech startup secures $2.3M to accelerate AI tools, double workforce - The Business Journals
IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook - Yahoo Finance
Morgan Stanley Raises iRhythm (IRTC) Price Target, Maintains Overweight Rating - MSN
Artificial Intelligence in Remote Patient Monitoring Market - openPR.com
Artificial Intelligence in Remote Patient Monitoring Market Poised to Grow at 27.13% CAGR Through 2032, Reports DelveInsight | Medtronic, iRhythm, Philips, Siemens Healthineers, GE HealthCare, etc - Barchart.com
Morgan Stanley Maintains Buy Rating for Irhythm Technologies with $195 Price Target - AInvest
Chad Patterson Sells 2,555 Shares of iRhythm Technologies Inc, Modestly Overvalued According to GF Value - AInvest
Don't Ignore The Insider Selling In iRhythm Technologies - simplywall.st
iRhythm Technologies' Chief Commercial Officer Sells 2,555 Shares - AInvest
iRhythm Fails to Halt Information Exchange in Investor Lawsuit - Bloomberg Law News
Top Executives Cash Out Big on Irhythm Technologies Stock! - TipRanks
Top Executives Cash Out on Irhythm Technologies Stock Amid Strong Earnings and Raised Price Targets. - AInvest
Stewart Won't Reconsider Her 1st Settled Expectations Denial - Law360
Stewart Denies iRhythm’s Bid to Review Decision Scrapping IPRs Based on ‘Settled Expectations’ - IPWatchdog.com
Insider Selling at iRhythm Technologies: Signal or Noise in a High-Flying Stock? - AInvest
Truist Financial Sticks to Their Buy Rating for Irhythm Technologies (IRTC) - The Globe and Mail
Truist Financial Reiterates Buy Rating for Irhythm Technologies with $175 Price Target - AInvest
iRhythm Technologies Sees Boosted Price Target Following Strong Earnings - AInvest
Why Are iRhythm Technologies Shares Dropping? - TipRanks
Is It Too Late To Consider Buying IRhythm Technologies, Inc. (NASDAQ:IRTC)? - 富途牛牛
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Volume Profile Shows Strong Base for iRhythm Technologies Inc.Smart Portfolio Optimization Tips - beatles.ru
What is the risk reward ratio of investing in iRhythm Technologies Inc. stockMaximize portfolio growth with strategic plans - Jammu Links News
What analysts say about iRhythm Technologies Inc. stockRapidly growing investment returns - Jammu Links News
How strong is iRhythm Technologies Inc. company’s balance sheetCapitalize on momentum-driven stocks - Jammu Links News
iRhythm’s Strategic Moves and Strong Q2 Performance Boost Stock - StocksToTrade
When is iRhythm Technologies Inc. stock expected to show significant growthUnlock superior stock analysis tools - Jammu Links News
How volatile is iRhythm Technologies Inc. stock compared to the marketTap into rapid wealth building techniques - Jammu Links News
Is iRhythm Technologies Inc. a growth stock or a value stockExponential return rates - Jammu Links News
What catalysts could drive iRhythm Technologies Inc. stock higher in 2025Achieve consistent profits with proven strategies - Jammu Links News
Is it the right time to buy iRhythm Technologies Inc. stockMaximize portfolio value with smart investment plans - Jammu Links News
How many analysts rate iRhythm Technologies Inc. as a “Buy”Identify breakout stocks before they peak - Jammu Links News
How does iRhythm Technologies Inc. compare to its industry peersBuild a diversified portfolio for risk management - Jammu Links News
What are the latest earnings results for iRhythm Technologies Inc.Tremendous return rates - Jammu Links News
Does iRhythm Technologies Inc. stock perform well during market downturnsBuild wealth steadily with smart stock selection - Jammu Links News
What institutional investors are buying iRhythm Technologies Inc. stockGame-changing capital returns - Jammu Links News
What are iRhythm Technologies Inc. company’s key revenue driversRapid profit acceleration - Jammu Links News
iRhythm Technologies Reports Strong Q2 2025 Earnings - The Globe and Mail
iRhythm Technologies (IRTC): Is This MedTech Innovator Poised for Sustained Growth Amid Strategic AI Collaborations and Strong Q2 Performance? - AInvest
iRhythm Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
IRTC’s Impressive Growth: What’s Next? - timothysykes.com
IRTC’s Big Leap: Exploring Recent Moves - StocksToTrade
Sensus Healthcare shares rise 1.61% intraday after IRhythm and Lucem Health partnership for predictive AI in arrhythmia detection. - AInvest
1.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):